Nvidia, Apple, and Alphabet Could Help This Marvelous Vanguard ETF Turn $250,000 Into $1 Million After the Stock Market Sell-Off

Key Points The Nasdaq-100 technology index recently entered correction territory amid ongoing tensions in the Middle East. The Vanguard Mega Cap Growth ETF exclusively invests ...

Read more

Best Growth Stocks to Buy for April 8th

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today April 8th: CommScope COMM: This company which is a ...

Read more

Rocket Lab Gets Approval to Acquire Mynaric: Why This Matters

Rocket Lab has taken a major step forward in its vertical integration strategy. The company announced that it has received regulatory approval to acquire Mynaric, ...

Read more

Rising Food Prices Could Force the Fed’s Hand. Here Is the Chain Reaction Investors Are Not Talking About Enough

Key Points The geopolitical conflict in the Middle East has left energy markets in disarray. Energy is used for transportation, and investors are already feeling ...

Read more

Buy UnitedHealth or Humana Stock as Medicare Advantage Rates Increase?

The Centers for Medicare & Medicaid Services (CMS) finalized a much larger-than-expected increase in Medicare Advantage payment rates for 2027, triggering a broad relief rally ...

Read more

I’ve Changed My Mind on AMD Stock. The AI Supercycle Has Room for More Than Just Nvidia.

Key Points AMD has long lived in the shadow of Nvidia. However, the company is starting to make more inroads with its GPUs as the ...

Read more

Syntec Optics’ 2025 Loss Narrows Y/Y on Margin Expansion, Cost Cuts

Shares of Syntec Optics Holdings, Inc. OPTX have outperformed the broader market following the release of its latest quarterly results. Since the earnings announcement for ...

Read more

AI Stock Sell-Off: The 5 Best Stocks to Buy Right Now

Key Points The AI computing unit providers are projected to have strong growth over the next few years. Microsoft and Meta Platforms each delivered incredible ...

Read more

ONFO Stock Gains 2.9% Despite Wider Y/Y Loss in 2025, Revenues Rise

Shares of Onfolio Holdings, Inc. ONFO have gained 2.9% since reporting results for 2025, underperforming the S&P 500 index’s 3.9% advance. However, over the past ...

Read more

Precigen Reports ‘Robust Uptake’ Of New Drug For Rare Respiratory Disease; First Quarter Revenue Expected

Precigen Reports ‘Robust Uptake’ Of New Drug For Rare Respiratory Disease; First Quarter Revenue Expected – Benzinga Zinger Key Point: Plans underway to expand use ...

Read more